Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-02

Clinical Trial Update: A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [NA]

View source ↗

Summary

This completed clinical trial compared Epivir plus Crixivan with either Zerit or Retrovir in antiretroviral-naive HIV-infected patients. The study evaluated out…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crixivan (indinavir)
  • Epivir (Lamivudine)
  • RETROVIR (Zidovudine)
  • Zerit (stavudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | NA | Status: COMPLETED